摘要:
Pharmaceutical combinations comprising at least one compound of general formula I-A or I-AA, and at lest one compound of general formula II) or Iia), or pharmaceutical combinations comprising at least one compound of general formula I-A or I-AA, and at least one compound of general formula II) or Iia), and an anti-hormone, and their use for the treatment of different diseases resulting by persistent angiogenesis are described.
摘要:
Electrostatic dust collector comprising a first (1) and a second electrode (2), a voltage source (3) for applying a voltage between the two electrodes (1, 2), and a connection to ground (2a) is provided. The first electrode (1) and the second electrode (2) form a dust collection device, the first electrode (1) being positively charged and the second electrode (2) being negatively charged.
摘要:
Electrostatic dust collector comprising a first (1) and a second electrode (2), a voltage source (3) for applying a voltage between the two electrodes (1, 2), and a connection to ground (2a) is provided. The first electrode (1) and the second electrode (2) form a dust collection device, the first electrode (1) being positively charged and the second electrode (2) being negatively charged.
摘要:
The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of an anti-apoptotic gene, comprising a complementary RNA strand having a nucleotide sequence which is less that 25 nucleotides in length and which is substantially identical to at least a part of an apoptotic gene, such as a Bcl gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of an anti-apoptotic gene using the pharmaceutical composition; and methods for inhibiting the expression of an anti-apoptotic gene in a cell.